Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea
- PMID: 8393054
- DOI: 10.1093/infdis/168.2.282
Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea
Abstract
A cohort of newborns in New Delhi who were nosocomially infected with rotavirus during their first days of life were followed twice weekly for 14-23 months to determine whether neonatal infection protected them against subsequent episodes of rotavirus diarrhea. Infection occurred in 60% by the fourth day of life, was asymptomatic, and was caused predominantly by an unusual rotavirus strain (G9 P11) not previously identified in humans. The 148 children with neonatal rotavirus infection had 46% fewer attacks of rotavirus diarrhea in the follow-up period than the 56 infants without nosocomial infection (0.23 vs. 0.42 episodes/child-year, P < .05). This protection was concentrated among infants in their first year of life and was not associated with a significant decrease in disease severity. Consideration of this strain as a vaccine candidate will require further assessment of its natural protection under field conditions.
Similar articles
-
Rotavirus infection in infants as protection against subsequent infections.N Engl J Med. 1996 Oct 3;335(14):1022-8. doi: 10.1056/NEJM199610033351404. N Engl J Med. 1996. PMID: 8793926
-
An epidemiological study of rotavirus diarrhoea in a cohort of Nigerian infants: II. Incidence of diarrhoea in the first two years of life.Int J Epidemiol. 1988 Dec;17(4):908-12. doi: 10.1093/ije/17.4.908. Int J Epidemiol. 1988. PMID: 3225102
-
Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India.J Infect Dis. 2007 Mar 1;195(5):625-32. doi: 10.1086/510853. Epub 2007 Jan 22. J Infect Dis. 2007. PMID: 17262703 Free PMC article.
-
Correlates of protection against rotavirus infection and disease.Novartis Found Symp. 2001;238:106-13; discussion 114-24. doi: 10.1002/0470846534.ch8. Novartis Found Symp. 2001. PMID: 11444023 Review.
-
[Rotaviruses in human and veterinary medicine].Sante. 1997 May-Jun;7(3):195-9. Sante. 1997. PMID: 9296811 Review. French.
Cited by
-
Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.Pharmacoeconomics. 2011 Nov;29(11):989-1009. doi: 10.2165/11207210-000000000-00000. Pharmacoeconomics. 2011. PMID: 21988293 Review.
-
Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains.Clin Diagn Lab Immunol. 1998 Jul;5(4):527-30. doi: 10.1128/CDLI.5.4.527-530.1998. Clin Diagn Lab Immunol. 1998. PMID: 9665961 Free PMC article.
-
Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries.Paediatr Drugs. 2012 Dec 1;14(6):429-33. doi: 10.2165/11207500-000000000-00000. Paediatr Drugs. 2012. PMID: 23013458 Review.
-
Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countries.Drugs R D. 2012 Dec 1;12(4):239-44. doi: 10.2165/11208130-000000000-00000. Drugs R D. 2012. PMID: 23017130 Free PMC article.
-
Cytokines as mediators for or effectors against rotavirus disease in children.Clin Diagn Lab Immunol. 2003 Nov;10(6):995-1001. doi: 10.1128/cdli.10.6.995-1001.2003. Clin Diagn Lab Immunol. 2003. PMID: 14607858 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical